These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6119134)

  • 21. Sulphasalazine in rheumatoid arthritis.
    Pullar T; Hunter JA; Capell HA
    Lancet; 1985 May; 1(8438):1167. PubMed ID: 2860375
    [No Abstract]   [Full Text] [Related]  

  • 22. Sulphasalazine induced selective IgA deficiency in rheumatoid arthritis.
    Delamere JP; Farr M; Grindulis KA
    Br Med J (Clin Res Ed); 1983 May; 286(6377):1547-8. PubMed ID: 6133577
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of white blood cell dyscrasias during sulphasalazine therapy of rheumatoid arthritis and inflammatory bowel disease.
    Capell HA; Pullar T; Hunter JA
    Drugs; 1986; 32 Suppl 1():44-8. PubMed ID: 2877852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
    Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sulphasalazine induced agranulocytosis in a patient with rheumatoid arthritis.
    Murphy PT; O'Donnell JR
    Ir J Med Sci; 1990 Jun; 159(6):195. PubMed ID: 1977725
    [No Abstract]   [Full Text] [Related]  

  • 26. Sulphasalazine in the treatment of rheumatoid arthritis: a renewed challenge.
    van Riel PL; van de Putte LB
    Neth J Med; 1990 Jun; 36(5-6):221-2. PubMed ID: 1975649
    [No Abstract]   [Full Text] [Related]  

  • 27. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
    Pullar T; Hunter JA; Capell HA
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1102-4. PubMed ID: 6138117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypogammaglobulinaemia and thrombocytopenia associated with sulphasalazine therapy in rheumatoid arthritis.
    Farr M; Tunn E; Bacon PA; Smith DH
    Ann Rheum Dis; 1985 Oct; 44(10):723-4. PubMed ID: 2864899
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experience with sulphasalazine (salazopyrin) in the treatment of rheumatoid arthritis].
    Winkler V
    Orv Hetil; 1986 Aug; 127(34):2073-4, 2079-80. PubMed ID: 2876405
    [No Abstract]   [Full Text] [Related]  

  • 30. Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years.
    Amos RS; Pullar T; Bax DE; Situnayake D; Capell HA; McConkey B
    Br Med J (Clin Res Ed); 1986 Aug; 293(6544):420-3. PubMed ID: 2874863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sulphasalazine in rheumatoid arthritis: an old drug revived.
    Neumann VC; Grindulis KA
    J R Soc Med; 1984 Mar; 77(3):169-72. PubMed ID: 6142116
    [No Abstract]   [Full Text] [Related]  

  • 32. Sulphasalazine hepatotoxicity: lack of a hypersensitivity response.
    MacGilchrist AJ; Hunter JA
    Ann Rheum Dis; 1986 Nov; 45(11):967-8. PubMed ID: 2878646
    [No Abstract]   [Full Text] [Related]  

  • 33. Long term outcome of treatment with sulphasalazine in rheumatoid arthritis.
    Situnayake RD; McConkey B
    Drugs; 1986; 32 Suppl 1():71-2. PubMed ID: 2877857
    [No Abstract]   [Full Text] [Related]  

  • 34. Leucopenia during sulphasalazine treatment for rheumatoid arthritis.
    Marabani M; Madhok R; Capell HA; Hunter JA
    Ann Rheum Dis; 1989 Jun; 48(6):505-7. PubMed ID: 2568110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variables affecting efficacy and toxicity of sulphasalazine in rheumatoid arthritis. A review.
    Pullar T; Capell HA
    Drugs; 1986; 32 Suppl 1():54-7. PubMed ID: 2877854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.
    Boers M; Verhoeven AC; Markusse HM; van de Laar MA; Westhovens R; van Denderen JC; van Zeben D; Dijkmans BA; Peeters AJ; Jacobs P; van den Brink HR; Schouten HJ; van der Heijde DM; Boonen A; van der Linden S
    Lancet; 1997 Aug; 350(9074):309-18. PubMed ID: 9251634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should tests for proteinuria be included in the monitoring schedule of sulphasalazine?
    Helliwell PS
    Br J Rheumatol; 1995 Aug; 34(8):790-1. PubMed ID: 7551669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetylation, sulphasalazine and its effects.
    Astbury C; Taggart AJ
    Br J Rheumatol; 1987 Jun; 26(3):229-30. PubMed ID: 2884010
    [No Abstract]   [Full Text] [Related]  

  • 39. Lymphoma-like presentation in suspected rheumatoid arthritis due to sulphasalazine hypersensitivity syndrome.
    Shenoy P; Misra R; Jain M; Agarwal V
    N Z Med J; 2008 Jun; 121(1276):102-5. PubMed ID: 18574514
    [No Abstract]   [Full Text] [Related]  

  • 40. Rheumatoid arthritis: a risk factor for sulphasalazine toxicity? A meta-analysis.
    Wijnands MJ; Van 'T Hof MA; Van De Putte LB; Van Riel PL
    Br J Rheumatol; 1993 Apr; 32(4):313-8. PubMed ID: 8096419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.